Q&M Dental Group - Phillip Securities 2024-03-18: Data-driven Treatments Can Commence

• Q&M Dental Group (SGX:QC7)'s 2023 adjusted PATMI exceeded our expectations at 121% of forecasts. Operating margins recovered from higher revenue per patient and more stable employee expenses. Associates also turned around from losses the prior year.
• - Read this at SGinvestors.io -
• We upgraded Q&M from ACCUMULATE to BUY and raised our target price to S$0.36 (previously S$0.34).
• - Read this at SGinvestors.io -

The Positive

Recover in revenue and margins.

• 2H23 revenue growth is the fastest over the past two years. Despite fewer clinics, revenue expanded from higher revenue per patient. Using data driven treatment, Q&M can ascertain and provide a more intensive treatment for patients.
• Margins recovered from operating leverage and a stable number of staff or nurses.

The Negative

Declining number of clinics.

• Read more at SGinvestors.io.

Above is an excerpt from a report by Phillip Securities Research.
Clients of Phillip Capital may be the first to access the full PDF report @ https://www.stocksbnb.com/.

Read also Phillip's most recent report:
2025-03-13 Q&M Dental - Reorganising For Future Growth.

Previous report by Phillip:
2025-02-11 Q&M Dental - Growth Drivers Appearing.

Price targets by other brokers at Q&M Dental Target Prices.

Listing of research reports at Q&M Dental Analyst Reports.

Relevant links:
Q&M Dental Share Price History,
Q&M Dental Announcements,
Q&M Dental Dividend Payout Dates & Corporate Actions,
Q&M Dental News